Alumni raised $1.45B in 2022 - Download Free Report Now

EMcision (Acquired)

Endoscopic device for tumor ablation via ERCP using radiofrequency energy in patients with advanced and inoperable pancreatic cancer and cholangiocarc....

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of EMcision (Acquired) plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About EMcision (Acquired)

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

CEO presentation

Competing Startups


Companies We Work With